Revised forecast
Fiscal year ending May 2026 · Full yearPrevious forecast published 12 December 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Orders in the Chemicals and Pharmaceuticals businesses have remained strong, and costs related to the withdrawal from the Health Foods business are expected to be lower than anticipated.
| Item | Details |
|---|---|
| Net Sales | ¥7,500 million → ¥7,700 million（+2.7%） |
| Operating profit | ¥550 million → ¥700 million（+27.3%） |
| Ordinary income | ¥510 million → ¥660 million（+29.4%） |
| Profit attributable to owners of the parent | ¥350 million → ¥470 million（+34.3%） |
| Net income per share | 87.14 yen and sen → 117.02 yen and sen |
| Fiscal Period Covered | Fiscal year ending May 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 12 December 2025 |
| Previous-period results | Sales ¥6,653 million, operating income ¥432 million, ordinary income ¥430 million, net income ¥241 million, and net income per share ¥60.42 (full year of the fiscal year ended May 2025) |
| Reason for the revision | Orders in the Chemicals and Pharmaceuticals businesses have remained strong, and costs related to the withdrawal from the Health Foods business are expected to be lower than anticipated. |
| Dividend forecast revision | The year-end dividend will be increased from ¥15.00 to ¥16.00, and the annual dividend from ¥25.00 to ¥26.00 |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Orders in the Chemicals and Pharmaceuticals businesses have remained strong, and costs related to the withdrawal from the Health Foods business are expected to be lower than anticipated.